You may be right. Astra Z has a pretty s*itty track record. I have a lot of relatives in EU and most have taken the PF vaccine, not the Astra Z. This should open the door for Valvena as one of the top vaccines in EU. It may open the door for the US if they go for FDA approval. A lot of people are afraid in the US to take mRNA vaccines. This vaccine is made like the regular Flu Shot. You can also buy Valvena on OTC under a different ticker name. They trade on 3 platforms including France.
Tread carefully now. Be prepared to buy at the dips. 1- Next month is their 3rd quarter earnings release. Second quarter was (-1.46) per share This quarter will probably be more because of all the expenses for Phase 3 trials. I'm anticipating the stock will drop unless of course they get regulatory approval. Then, whatever happens with their earnings (+) or (-) it wont make a difference. The stock will skyrocket.
Market Data 
Markets 
AI
